Clinical Trial

American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)

Study acronym: AI-CRIC
Recruiting
View on ClinicalTrials.gov →
Summary
Despite many advances in our understanding of the natural history and progression of chronic kidney disease (CKD) and cardio vascular disease (CVD) in the parent CRIC study over the past 15 years, important questions about key risk factors for these diseases remain unanswered in the AI population. To address this burden of CKD in AI communities Investigators formed a consortium of investigators with extensive experience in conducting research of chronic diseases including diabetes, cardiovascular and kidney disease in AIs of Southwestern US. The proposed CRIC ancillary cohort study of 500 AIs (AI-CRIC) will rapidly improve our understanding of both potential risk factors for CKD progression, as well as the scope of this disease among AIs. This study leverages the current CRIC study and incorporates the planned activities of the next phase of the study - "CRIC 2018" - by implementing contemporary CRIC protocols for kidney and cardiovascular measurement and outcomes.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2019-12-02; most recent amendment 2026-05-18.
Status change: Not Yet Recruiting → Recruiting 2021-04-27
Trial Details
NCT Number NCT04185844
Lead Sponsor University of New Mexico
Conditions Diabetes Mellitus, Chronic Kidney Diseases, Heart Diseases, Cardiovascular Diseases
Enrollment 500 participants
Start Date 2020-08-31
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-20